<i>GSTM1</i> and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload

Chronic blood transfusions in patients with sickle cell anemia (SCA) cause iron overload, which occurs with a degree of interpatient variability in serum ferritin and liver iron content (LIC). Reasons for this variability are unclear and may be influenced by genes that regulate iron metabolism. We e...

Full description

Bibliographic Details
Main Authors: Latika Puri, Jonathan M. Flanagan, Guolian Kang, Juan Ding, Wenjian Bi, Beth M. McCarville, Ralf B. Loeffler, Aaryani Tipirneni-Sajja, Martha Villavicencio, Kristine R. Crews, Claudia M. Hillenbrand, Jane S. Hankins
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/8/11/1878
id doaj-4ab53f2df77d4b29a049feb0d7e31113
record_format Article
spelling doaj-4ab53f2df77d4b29a049feb0d7e311132020-11-25T01:18:38ZengMDPI AGJournal of Clinical Medicine2077-03832019-11-01811187810.3390/jcm8111878jcm8111878<i>GSTM1</i> and Liver Iron Content in Children with Sickle Cell Anemia and Iron OverloadLatika Puri0Jonathan M. Flanagan1Guolian Kang2Juan Ding3Wenjian Bi4Beth M. McCarville5Ralf B. Loeffler6Aaryani Tipirneni-Sajja7Martha Villavicencio8Kristine R. Crews9Claudia M. Hillenbrand10Jane S. Hankins11Department of Hematology, St Jude Children’s Research Hospital, Memphis, TN 38105, USADivision of Hematology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USADepartment of Biostatistics, St Jude Children’s Research Hospital, Memphis, TN 38105, USADepartment of Biostatistics, St Jude Children’s Research Hospital, Memphis, TN 38105, USADepartment of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI 48109, USADepartment of Diagnostic Imaging, St Jude Children’s Research Hospital, Memphis, TN 38105, USADepartment of Research Imaging, University of New South Wales, Randwick, NSW 2052, AustraliaDepartment of Biomedical Engineering, University of Memphis, Memphis, TN 38105, USADepartment of Hematology, St Jude Children’s Research Hospital, Memphis, TN 38105, USADepartment of Pharmaceutical Sciences, St Jude Children’s Research Hospital, Memphis, TN 38105, USADepartment of Research Imaging, University of New South Wales, Randwick, NSW 2052, AustraliaDepartment of Hematology, St Jude Children’s Research Hospital, Memphis, TN 38105, USAChronic blood transfusions in patients with sickle cell anemia (SCA) cause iron overload, which occurs with a degree of interpatient variability in serum ferritin and liver iron content (LIC). Reasons for this variability are unclear and may be influenced by genes that regulate iron metabolism. We evaluated the association of the copy number of the glutathione S-transferase M1 (<i>GSTM1</i>) gene and degree of iron overload among patients with SCA. We compared LIC in 38 children with SCA and &#8805;12 lifetime erythrocyte transfusions stratified by <i>GSTM1</i> genotype. Baseline LIC was measured using magnetic resonance imaging (MRI), R2*MRI within 3 months prior to, and again after, starting iron unloading therapy. After controlling for weight-corrected transfusion burden (mL/kg) and splenectomy, mean pre-chelation LIC (mg/g dry liver dry weight) was similar in all groups: <i>GSTM1</i> wild-type (WT) (11.45, SD&#177;6.8), heterozygous (8.2, SD&#177;4.52), and homozygous <i>GSTM1</i> deletion (<i>GSTM1</i>-null; 7.8, SD&#177;6.9, <i>p</i> = 0.09). However, after &gt;12 months of chelation, <i>GSTM1</i>-null genotype subjects had the least decrease in LIC compared to non-null genotype subjects (mean LIC change for <i>GSTM1</i>-null = 0.1 (SD&#177;3.3); versus &#8722;0.3 (SD&#177;3.0) and &#8722;1.9 (SD&#177;4.9) mg/g liver dry weight for heterozygous and WT, respectively, <i>p</i> = 0.047). <i>GSTM1</i> homozygous deletion may prevent effective chelation in children with SCA and iron overload.https://www.mdpi.com/2077-0383/8/11/1878sickle cell anemiairon overloadglutathione s-transferase m1 (gstm1)chelation therapy
collection DOAJ
language English
format Article
sources DOAJ
author Latika Puri
Jonathan M. Flanagan
Guolian Kang
Juan Ding
Wenjian Bi
Beth M. McCarville
Ralf B. Loeffler
Aaryani Tipirneni-Sajja
Martha Villavicencio
Kristine R. Crews
Claudia M. Hillenbrand
Jane S. Hankins
spellingShingle Latika Puri
Jonathan M. Flanagan
Guolian Kang
Juan Ding
Wenjian Bi
Beth M. McCarville
Ralf B. Loeffler
Aaryani Tipirneni-Sajja
Martha Villavicencio
Kristine R. Crews
Claudia M. Hillenbrand
Jane S. Hankins
<i>GSTM1</i> and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload
Journal of Clinical Medicine
sickle cell anemia
iron overload
glutathione s-transferase m1 (gstm1)
chelation therapy
author_facet Latika Puri
Jonathan M. Flanagan
Guolian Kang
Juan Ding
Wenjian Bi
Beth M. McCarville
Ralf B. Loeffler
Aaryani Tipirneni-Sajja
Martha Villavicencio
Kristine R. Crews
Claudia M. Hillenbrand
Jane S. Hankins
author_sort Latika Puri
title <i>GSTM1</i> and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload
title_short <i>GSTM1</i> and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload
title_full <i>GSTM1</i> and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload
title_fullStr <i>GSTM1</i> and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload
title_full_unstemmed <i>GSTM1</i> and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload
title_sort <i>gstm1</i> and liver iron content in children with sickle cell anemia and iron overload
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2019-11-01
description Chronic blood transfusions in patients with sickle cell anemia (SCA) cause iron overload, which occurs with a degree of interpatient variability in serum ferritin and liver iron content (LIC). Reasons for this variability are unclear and may be influenced by genes that regulate iron metabolism. We evaluated the association of the copy number of the glutathione S-transferase M1 (<i>GSTM1</i>) gene and degree of iron overload among patients with SCA. We compared LIC in 38 children with SCA and &#8805;12 lifetime erythrocyte transfusions stratified by <i>GSTM1</i> genotype. Baseline LIC was measured using magnetic resonance imaging (MRI), R2*MRI within 3 months prior to, and again after, starting iron unloading therapy. After controlling for weight-corrected transfusion burden (mL/kg) and splenectomy, mean pre-chelation LIC (mg/g dry liver dry weight) was similar in all groups: <i>GSTM1</i> wild-type (WT) (11.45, SD&#177;6.8), heterozygous (8.2, SD&#177;4.52), and homozygous <i>GSTM1</i> deletion (<i>GSTM1</i>-null; 7.8, SD&#177;6.9, <i>p</i> = 0.09). However, after &gt;12 months of chelation, <i>GSTM1</i>-null genotype subjects had the least decrease in LIC compared to non-null genotype subjects (mean LIC change for <i>GSTM1</i>-null = 0.1 (SD&#177;3.3); versus &#8722;0.3 (SD&#177;3.0) and &#8722;1.9 (SD&#177;4.9) mg/g liver dry weight for heterozygous and WT, respectively, <i>p</i> = 0.047). <i>GSTM1</i> homozygous deletion may prevent effective chelation in children with SCA and iron overload.
topic sickle cell anemia
iron overload
glutathione s-transferase m1 (gstm1)
chelation therapy
url https://www.mdpi.com/2077-0383/8/11/1878
work_keys_str_mv AT latikapuri igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
AT jonathanmflanagan igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
AT guoliankang igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
AT juanding igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
AT wenjianbi igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
AT bethmmccarville igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
AT ralfbloeffler igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
AT aaryanitipirnenisajja igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
AT marthavillavicencio igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
AT kristinercrews igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
AT claudiamhillenbrand igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
AT janeshankins igstm1iandliverironcontentinchildrenwithsicklecellanemiaandironoverload
_version_ 1725141444630413312